Td Asset Management Inc Aadi Bioscience, Inc. Transaction History

Td Asset Management Inc

  • $107 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 27, 2023
BUY
$4.84 - $7.13 $116,561 - $171,711
24,083 Added 100.0%
48,166 $233,000
Q2 2022

Aug 04, 2022
SELL
$11.57 - $17.92 $123,799 - $191,744
-10,700 Reduced 30.76%
24,083 $297,000
Q4 2021

Feb 10, 2022
BUY
$19.32 - $29.02 $672,007 - $1.01 Million
34,783 New
34,783 $840,000

Others Institutions Holding AADI

# of Institutions
55
Shares Held
12.6M
Call Options Held
23.8K
Put Options Held
0
View Full List

About Aadi Bioscience, Inc.

AADI Quotes by TradingView
  • Ticker AADI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 21,016,800
  • Market Cap $46.7M
  • Description
  • Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, ...
More about AADI
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email